Erratum: Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness (Journal of Thrombosis and Thrombolysis DOI: 10.1007/s11239-011-0665-7);Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 2, 2012, Pages 137-142

  Ibrahim, Homam ^a   Nadipalli, Srinivas ^a   DeLao, Timothy ^a   Guthikonda, Sasidhar ^a   Kleiman, Neal S ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Clopidogrel; Hypo responsiveness; Immature platelets; Platelet aggregation

Indexed keywords

CLOPIDOGREL;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIGHT TRANSITION AGGREGOMETRY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; VASODILATOR STIMULATED PHOSPHOPROTEIN PHOSPHORYLATION;

EID: 84858863131     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0686-x     Document Type: Erratum

References (28)

1. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494-502 (Pubitemid 32758501)
2. Mills DC, Puri R, Hu CJ, Minniti C, Grana G, Freedman MD et al (1992) Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb 12(4):430-436
3. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358(9281):527-533 (Pubitemid 32772726)
4. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C et al (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288(19):2411-2420 (Pubitemid 35340537)
5. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA et al (2007) Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49(14):1505-1516 (Pubitemid 46517957)
6. Bonello L, Armero S, Ait Mokhtar O, Mancini J, Aldebert P, Saut N et al (2010) Clopidogrel loading dose adjustment according to platelet reactivity monitoring in patients carrying the 2C19*2 loss of function polymorphism. J Am Coll Cardiol 56(20):1630-1636
7. Ferreiro JL, Angiolillo DJ (2009) Clopidogrel response variability: current status and future directions. Thromb Haemost 102(1):7-14
8. Ault KA, Knowles C (1995) In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 23(9):996-1001
9. Dale GL, Friese P, Hynes LA, Burstein SA (1995) Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood 85(7):1822-1825
10. Robinson M, MacHin S, Mackie I, Harrison P (2000) In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. Br J Haematol 108(4):859-864 (Pubitemid 30304523)
11. McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ (2004) Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol 126(6):861-869 (Pubitemid 39273828)
12. Lakkis N, Dokainish H, Abuzahra M, Tsyboulev V, Jorgensen J, De Leon AP et al (2004) Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 44(10):2091-2093 (Pubitemid 39473299)
13. Guthikonda S, Lev EI, Patel R, DeLao T, Bergeron AL, Dong JF et al (2007) Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 5(3):490-496 (Pubitemid 46680680)
14. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T et al (2008) Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 52(9):743-749
15. Pons I, Monteagudo M, Lucchetti G, Munoz L, Perea G, Colomina I et al (2010) Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia. Eur J Haematol 85(2):158-163
16. Kim HR, Park BR, Lee MK, Park AJ, Ahn JY (2007) Comparison of an immature platelet fraction and reticulated platelet in liver cirrhosis. Korean J Lab Med 27(1):7-12
17. Pankraz A, Bauer N, Moritz A (2009) Comparison of flow cytometry with the Sysmex XT2000iV automated analyzer for the detection of reticulated platelets in dogs. Vet Clin Pathol 38(1):30-38
18. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP et al (2005) Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POSTSTENTING study. J Am Coll Cardiol 46(10):1820-1826 (Pubitemid 41579802)
19. Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, Bernardo E et al (2007) Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the optimizing antiplatelet therapy in diabetes mellitus (OPTIMUS) study. Circulation 115(6):708-716 (Pubitemid 46294761)
20. Cesari F, Marcucci R, Caporale R, Paniccia R, Romano E, Gensini GF et al (2008) Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost 99(5):930-935 (Pubitemid 351705311)
21. Grove EL, Hvas AM, Kristensen SD (2009) Immature platelets in patients with acute coronary syndromes. Thromb Haemost 101(1):151-156
22. Grove EL, Hvas AM, Mortensen SB, Larsen SB, Kristensen SD (2011) Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 9(1):185-191
23. Wurtz M, Grove EL, Wulff LN, Kaltoft AK, Tilsted HH, Jensen LO et al (2010) Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets. JACC Cardiovasc Interv 3(8):828-835
24. Zanazzi M, Cesari F, Rosso G, Farsetti S, Caroti L, Gori AM et al (2010) Reticulated platelets and platelet reactivity in renal transplant recipients receiving antiplatelet therapy. Transplant Proc 42(4):1156-1157
25. Cesari F, Marcucci R, Gori AM, Caporale R, Fanelli A, Paniccia R et al (2010) High platelet turnover and reactivity in renal transplant recipients patients. Thromb Haemost 104(4):804-810
26. Perneby C, Wallen NH, Rooney C, Fitzgerald D, Hjemdahl P (2006) Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost 95(4):652-658
27. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N et al (2011) The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost 9(4):748-758
28. Shashkin PN, Brown GT, Ghosh A, Marathe GK, McIntyre TM (2008) Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol 181(5):3495-3502